Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs
<b>Background/Objectives:</b> Chronic lung diseases are among the leading causes of death worldwide. In the treatment of these diseases, non-steroidal anti-inflammatory drugs can be effective. We have previously developed an excipient formulation alongside a modern manufacturing protocol...
Saved in:
Main Authors: | Petra Party, Zsófia Ilona Piszman, Rita Ambrus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/6/923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental and analytical research of fine powders produced by spray freeze drying with active hydrodynamics
by: A. Y. Troyankin, et al.
Published: (2011-02-01) -
INHALATION THERAPY IN CHILDREN: ISSUES AND OPTIONS
by: L. R. Selimzyanova, et al.
Published: (2014-03-01) -
Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01) -
Effect of Meloxicam and Nano-meloxicam on selected haematological and immunological parameters in arthritis-induced male albino rats
by: Adel Bashar, et al.
Published: (2025-06-01) -
USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01)